HNRNPA2B1 and non-small cell lung carcinoma: HNRNPA2B1 as a nuclear reader is upregulated in esophageal cancer (ESCA) [11, 12], ovarian cancer [13], colorectal cancer (CRC) [14], multiple myeloma [15], oral squamous cell carcinoma (OSCC) [16], NSCLC [17] and associated with lymphatic metastasis and poor prognosis, acting as an oncogene in multiple malignancies [11–16].